St. Louis Alzheimer’s diagnostics company lands first U.S. insurance coverage
C2N Diagnostics announced July 10 that its blood-based Alzheimer’s diagnostic received its first U.S. insurance coverage, a reimbursement milestone for the St. Louis-area company.